Loading resource…

NEJM
Conducted as a double-blind, randomized, placebo-controlled trial, this research involved community-dwelling adults aged 70 and older with no history of cardiovascular disease, diabetes, or dementia. Participants were assigned to receive either atorvastatin or a placebo, with the study focusing on major cardiovascular events and disability-free survival as primary endpoints. The findings contribute to the ongoing debate regarding statin use in older populations, particularly in terms of safety and efficacy.
No account needed